European Union · Question · QUESTION_WRITTEN
E-10-2024-001556
COVID: raisons pour lesquelles la Commission a ouvert son appel d’offre 2024 de 146 millions de doses uniquement aux vaccins à ARNm, le vaccin d’AstraZeneca étant moins cher
Introduced
27 August 2024
Last action
18 October 2024 · Answer
Status
answered
Sponsors
Virginie JORON
Subjects
Discovery layer
Source updated
18 October 2024
Records
Official question E-10-2024-001556 from European Union at European Parliament. Dated 27 August 2024. Status: answered.
Timeline
27 August 2024
Written question
COVID: raisons pour lesquelles la Commission a ouvert son appel d’offre 2024 de 146 millions de doses uniquement aux vaccins à ARNm, le vaccin d’AstraZeneca étant moins cher
Source: QUESTION_WRITTEN
18 October 2024
Answer
Source: QUESTION_WRITTEN_ANSWER
Votes
No vote records are attached yet.
Versions
No version snapshots stored. Document URLs remain at the source.
Documents
5 official files
Answer
This file cannot be previewed here. Use View or Download.
Reading translation
Translate this document into your language. PoliticalRepo does not store a separate copy per EU language.
On-demand whole-document translation with a downloadable PDF (logo + link to the official source). The official file stays authoritative.
Answer
QUESTION_WRITTEN_ANSWER · 18 October 2024
COVID: why was the Commission’s 2024 call for tenders for the supply of 146 million vaccine doses open only to mRNA vaccines, despite the AstraZeneca vaccine being cheaper?
QUESTION_WRITTEN · EN · 6 September 2024
DownloadOpen at official source
Leesvertaling
Vertaal dit document naar jouw taal. PoliticalRepo bewaart geen aparte kopie per EU-taal.
Documentvertaling op verzoek met downloadbare PDF (logo + link naar de officiële bron). Het bronbestand blijft leidend.
COVID: why was the Commission’s 2024 call for tenders for the supply of 146 million vaccine doses open only to mRNA vaccines, despite the AstraZeneca vaccine being cheaper?
QUESTION_WRITTEN · EN · 6 September 2024
ViewDownloadOpen at official source
Leesvertaling
Vertaal dit document naar jouw taal. PoliticalRepo bewaart geen aparte kopie per EU-taal.
Documentvertaling op verzoek met downloadbare PDF (logo + link naar de officiële bron). Het bronbestand blijft leidend.
COVID: raisons pour lesquelles la Commission a ouvert son appel d’offre 2024 de 146 millions de doses uniquement aux vaccins à ARNm, le vaccin d’AstraZeneca étant moins cher
QUESTION_WRITTEN · FR · 6 September 2024
DownloadOpen at official source
Reading translation
Translate this document into your language. PoliticalRepo does not store a separate copy per EU language.
On-demand whole-document translation with a downloadable PDF (logo + link to the official source). The official file stays authoritative.
COVID: raisons pour lesquelles la Commission a ouvert son appel d’offre 2024 de 146 millions de doses uniquement aux vaccins à ARNm, le vaccin d’AstraZeneca étant moins cher
QUESTION_WRITTEN · FR · 6 September 2024
ViewDownloadOpen at official source
Reading translation
Translate this document into your language. PoliticalRepo does not store a separate copy per EU language.
On-demand whole-document translation with a downloadable PDF (logo + link to the official source). The official file stays authoritative.
Sponsors
- · COM · ADDRESSEE
- Virginie JORON · AUTHOR
Related records
No cross-record relationships stored yet.
Sources
PoliticalRepo is an index and interpretation layer, not the authoritative legal source.
- Official source: https://www.europarl.europa.eu/doceo/document/E-10-2024-001556_EN.html
- Open data entity: https://data.europarl.europa.eu/api/v2/parliamentary-questions/E-10-2024-001556
- eu · E-10-2024-001556 · source updated 18 October 2024